Of these 23 adenocarcinoma samples, 18 were found to be suitable for LGR5 ISH analysis, and consistent with the previous reports we generally observed LGR5 expression in the proximal portion of the gland in adenocarcinomas of all clinical stages (Fig. 6A, B and Supplementary Fig. S5). This evidence concerns the gene LGR5 and adenocarcinoma.